About Bihua Chen
Bihua Chen is a director and 10% owner at BlossomHill Therapeutics.
Form D filings also name Bihua Chen as a director at BiVACOR and BioVentrix.
Bihua Chen reports to the SEC as a director, officer or major shareholder of 42 public companies, including BridgeBio Oncology Therapeutics (BBOT), Bright Minds Biosciences (DRUG) and Helix Acquisition Corp. III (HLXC).
Bihua Chen first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Bihua Chen in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
CEO and Chairperson
2024 – 2026 · Public company (BBOT)
BI
HI
Helix Acquisition Corp. III
Chairperson and CEO
2026 · Public company (HLXC)
CI
Corbus Pharmaceuticals Holdings, Inc.
10% owner
2024 – 2025 · Public company (CRBP)
EI
EyePoint, Inc.
10% owner
2023 – 2025 · Public company (EYPT)
MI
MoonLake Immunotherapeutics
CEO and Chairman
2020 – 2025 · Public company (MLTX)
BI
Biomea Fusion, Inc.
Director and 10% owner
2021 – 2025 · Public company (BMEA)
OI
OnKure Therapeutics, Inc.
10% owner
2024 – 2025 · Public company (OKUR)
AI
BI
IC
Immuneering Corp
10% owner
2021 – 2024 · Public company (IMRX)
AI
Ambrx Biopharma, Inc.
10% owner
2023 · Public company (AMAM)
AI
Ambrx Biopharma Inc.
10% owner
2023 · Public company (AMAM)
GP
GreenLight Biosciences Holdings, PBC
Reporting person
2023 · Public company (GRNA)
EI
Erasca, Inc.
Director and 10% owner
2021 – 2023 · Public company (ERAS)
Bioventrix, Inc.
Director
2023 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
VI
Vigil Neuroscience, Inc.
10% owner
2022 · Public company (VIGL)
VI
Ventyx Biosciences, Inc.
10% owner
2021 · Public company (VTYX)
PI
Pyxis Oncology, Inc.
10% owner
2021 · Public company (PYXS)
TI
Tyra Biosciences, Inc.
10% owner
2021 · Public company (TYRA)
II
Icosavax, Inc.
10% owner
2021 · Public company (ICVX)
JI
Jade Biosciences, Inc.
10% owner
2021 · Public company (JBIO)
EI
Elevation Oncology, Inc.
10% owner
2021 · Public company (ELEV)
MI
Monte Rosa Therapeutics, Inc.
Director and 10% owner
2021 · Public company (GLUE)
VI
Verve Therapeutics, Inc.
Director and 10% owner
2021 · Public company (VERV)
RI
Rain Oncology Inc.
Director and 10% owner
2021 · Public company (RAIN)
DI
Design Therapeutics, Inc.
Director and 10% owner
2021 · Public company (DSGN)
PI
Prometheus Biosciences, Inc.
Director and 10% owner
2021 · Public company (RXDX)
BI
BioAtla, Inc.
Director and 10% owner
2020 · Public company (BCAB)
OI
Olema Pharmaceuticals, Inc.
Director and 10% owner
2020 · Public company (OLMA)
AI
Atea Pharmaceuticals, Inc.
Director and 10% owner
2020 · Public company (AVIR)
AI
Akouos, Inc.
Director and 10% owner
2020 · Public company (AKUS)
AI
Avidity Biosciences, Inc.
Director and 10% owner
2020 · Public company (RNAM)
TI
Turning Point Therapeutics, Inc.
Director and 10% owner
2019 · Public company (TPTX)
AI
Axonics, Inc.
Director and 10% owner
2018 · Public company (AXNX)
CI
Constellation Pharmaceuticals Inc.
Director and 10% owner
2018 · Public company (CNST)
KI
Kezar Life Sciences, Inc.
Director and 10% owner
2018 · Public company (KZR)
KP
Kiniksa Pharmaceuticals International, plc
Director and 10% owner
2018 · Public company (KNSA)
KI
Kineta, Inc.
Director and 10% owner
2016 – 2017 · Public company (KANT)
AI
Apellis Pharmaceuticals, Inc.
Director and 10% owner
2017 · Public company (APLS)
CI
Clearside Biomedical, Inc.
Director and 10% owner
2016 · Public company (CLSD)
CI
Cellectar Biosciences, Inc.
Director and 10% owner
2014 · Public company (CLRB)
Key Colleagues at Startups
The people Bihua Chen works with at each company, as listed on that company's latest Form D.
BlossomHill Therapeutics, Inc. · Form D, Dec 10, 2025
GL
George Lee
Director
CG
Carl Gordon
Director
YL
Yishan Li
Executive officer and director
SA
Sundeep Agrawal
Director
TS
Timothy Stubbs
Director
JC
Jingrong Jean Cui
President and Chief Executive Officer, director
BiVACOR Inc. · Form D, Aug 6, 2024
MM
Matt Mackey
Director
RK
Raymond Kelleher
Director
DT
Daniel Timms
Executive officer and director
RC
Raymond Cohen
Director
JJ
Jeannette Joughin
Director
JD
James Dillon
Chief Executive Officer and director
PK
Paul Kelly
Director
Bioventrix, Inc. · Form D, Apr 4, 2023
RC
Raymond Cohen
Director
Steve Chartier
Executive officer
JD
James Dillon
Executive officer and director
David Richmond
Co-Chief Executive Officer and director
AH
Andrew Hinson
Director
AC
Andrew Coats
Director
MT
Michael Taglich
Director
RW
Raphael Wisniewski
Director
RS
Rinda Sama
Director
OY
Ori Ben-Yehuda
Executive officer
WA
William Abbott
Chief Financial Officer
CW
Christopher Wolff
Executive officer